EFNA2 Gene — Ephrin A2

EFNA2 Gene — Ephrin A2

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">EFNA2 Gene — Ephrin A2</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>EFNA2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ephrin A2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>19p13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1943</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>596339</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000146700</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O43923</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>205 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~22 kDa</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Binding Affinity</td>
</tr>
<tr>
<td class="label">EPHA2</td>
<td>High</td>
</tr>
<tr>
<td class="label">EPHA4</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">EPHA5</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">EPHA8</td>
<td>Low</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

EFNA2 Gene — Ephrin A2

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">EFNA2 Gene — Ephrin A2</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>EFNA2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ephrin A2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>19p13.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1943</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>596339</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000146700</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O43923</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>205 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~22 kDa</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Binding Affinity</td>
</tr>
<tr>
<td class="label">EPHA2</td>
<td>High</td>
</tr>
<tr>
<td class="label">EPHA4</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">EPHA5</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">EPHA8</td>
<td>Low</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

EFNA2 (Ephrin A2) is a member of the ephrin family of membrane-bound ligands that bind to Eph (Ephrin) receptors. As a GPI-anchored protein, EFNA2 mediates bidirectional signaling with EPHA receptors, playing crucial roles in neural development, synaptic plasticity, and neuronal function. Recent research has identified EFNA2 as a significant player in neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease), where it influences amyloid-beta clearance, synaptic integrity, and cognitive function. [@chen2022]

Overview

EFNA2 is a member of the ephrin-A family, which comprises five GPI-anchored ligands (EFNA1-5) that primarily bind to EPHA (Ephrin type-A receptor) class of tyrosine kinases. The EFNA2 gene encodes a protein that is expressed prominently in the central nervous system, particularly in regions associated with learning and memory such as the [hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex). The protein plays essential roles in:

• Neural circuit formation during development
• Synaptic plasticity and function in the adult brain
• Activity-dependent modifications of dendritic spines
• Regulation of amyloid-beta clearance mechanisms

Gene Information

Protein Structure and Function

Structure

EFNA2 is a member of the ephrin family characterized by:

Forward Signaling (EFNA2 → EPHA)

When EFNA2 engages EPHA receptors on adjacent cells, it triggers forward signaling through:

• Ras/MAPK pathway
• PI3K/Akt pathway
• Rho family GTPases

Reverse Signaling (EPHA → EFNA2)

Unique among ligand-receptor systems, ephrin-A2 can also transmit signals in the reverse direction:

Expression Pattern

Brain Expression

EFNA2 shows region-specific expression in the central nervous system:

• High expression: Hippocampus (CA1, CA3, dentate gyrus), cortex (layer V pyramidal neurons), cerebellum (Purkinje cells)
• Moderate expression: Basal ganglia, thalamus, olfactory bulb
• Cellular localization: Primarily neuronal, with some expression in astrocytes and oligodendrocytes
• Subcellular localization: Enriched in dendritic spines and postsynaptic densities

Developmental Expression

During neural development, EFNA2 expression follows a precise temporal pattern:

• Embryonic stage: High expression in developing brain regions undergoing active neurogenesis
• Postnatal development: Expression increases during synaptogenesis, peaking during critical periods of plasticity
• Adult brain: Maintained at moderate levels, with activity-dependent regulation in mature neurons

Regulation by Neural Activity

EFNA2 expression is dynamically regulated by neuronal activity:

• Activity-dependent upregulation: Synaptic activity increases EFNA2 transcription
• Calcium-dependent regulation: NMDA receptor activation triggers EFNA2 expression
• Homeostatic scaling: Chronic activity changes modulate EFNA2 levels as part of homeostatic plasticity mechanisms [@li2012]

Role in Synaptic Plasticity

Dendritic Spines

EFNA2 plays a critical role in the formation, maintenance, and remodeling of dendritic spines:

Spine Formation

• EFNA2-EPHA2 signaling promotes spine genesis during development
• Activity-dependent EFNA2 clustering at nascent synapses facilitates spine formation
• Interaction with actin cytoskeleton regulators controls spine morphology

• EFNA2 reverse signaling maintains spine stability in mature neurons
• Chronic suppression of EFNA2 leads to spine loss and synaptic dysfunction
• The protein interacts with PSD-95 and other postsynaptic scaffold proteins

• EFNA2 signaling regulates actin dynamics in spines
• Ephrin-A2 reverse signaling controls AMPA receptor trafficking
• Activity-dependent spine plasticity requires EFNA2-mediated signaling [@yu2011]

Long-Term Potentiation (LTP)

EFNA2 is essential for LTP, the cellular basis of learning and memory:

Studies using EFNA2 knockout mice demonstrate significant deficits in LTP and impaired spatial memory formation, confirming the essential role of this ephrin ligand in hippocampal synaptic plasticity. [@chen2022]

Long-Term Depression (LTP)

EFNA2 also participates in LTD, the opposing form of synaptic plasticity:

• EFNA2-EPHA2 signaling modulates LTD induction
• Reverse signaling pathways regulate endocytosis of AMPA receptors during LTD
• Dysregulation of EFNA2 signaling contributes to aberrant synaptic depression in disease states

Alzheimer's Disease Pathogenesis

Amyloid-Beta Metabolism

EFNA2 plays a significant role in amyloid-beta metabolism and clearance:

Amyloid Clearance

• EPHA2-EFNA2 signaling regulates microglial phagocytosis of amyloid-beta plaques
• Activation of this pathway enhances amyloid clearance in mouse models of AD
• EFNA2 overexpression reduces amyloid burden and improves cognitive function [@liu2021]

• Amyloid-beta exposure alters EFNA2 expression and signaling
• Disruption of EFNA2-EPHA2 signaling contributes to synaptic toxicity
• Amyloid-induced microglial activation is modulated by EFNA2

Tau Pathology

EFNA2 is implicated in tau pathology and neurodegeneration:

• EFNA2 signaling regulates tau phosphorylation through PP2A and GSK3β pathways
• Tau oligomerization affects EFNA2 membrane distribution
• Loss of EFNA2 function exacerbates tau-induced synaptic deficits

Synaptic Dysfunction

In Alzheimer's disease, EFNA2 dysfunction contributes to synaptic failure:

Neuroinflammation

EFNA2 modulates neuroinflammatory responses in AD:

• EPHA2 receptors on microglia regulate inflammatory cytokine production
• EFNA2-EPHA2 signaling modulates microglial activation states
• Therapeutic targeting of this pathway reduces neuroinflammation in animal models [@chen2018]

Genetic Association with AD

GWAS Findings

Genome-wide association studies have identified EFNA2 variants associated with AD risk:

• rs with genome-wide significance: Certain EFNA2 polymorphisms correlate with late-onset AD risk
• Expression quantitative trait loci (eQTL): Risk variants affect EFNA2 expression levels in brain tissue
• Haplotype analysis: Specific EFNA2 haplotypes confer either protection or risk

Variant Functional Studies

Functional characterization of AD-associated EFNA2 variants reveals:

Therapeutic Implications

Drug Development

Targeting the EFNA2-EPHA2 axis represents a promising therapeutic strategy:

Gene Therapy Approaches

• Viral vector-mediated EFNA2 overexpression
• CRISPR-based editing of risk variants
• RNA interference to modulate expression

Research Directions

Current research focuses on:

• Developing brain-penetrant EPHA2 agonists
• Understanding cell-type specific functions of EFNA2
• Identifying biomarkers for EFNA2-targeted therapies
• Clinical trials of EPHA2-modulating compounds [@williams2019]

Animal Models

Mouse Models

• Efna2 knockout mice: Show learning and memory deficits
• Efna2 conditional knockouts: Cell-type specific deletion reveals neuronal versus glial functions
• AD model crosses: EFNA2 modulation affects amyloid and tau pathology in transgenic mice

In Vitro Models

• Primary neuron cultures: Study EFNA2 function in synaptic plasticity
• iPSC-derived neurons: Patient-specific models with EFNA2 variants
• Organoid systems: Three-dimensional brain models for EFNA2 research

Interaction Network

Receptor Interactions

Downstream Signaling Partners

• Adapter proteins: Grb2, Crk, Nck
• Enzymes: RasGAP, PI3K, PLCγ
• Cytoskeletal regulators: Rho GTPases, cofilin
• Synaptic proteins: PSD-95, NMDA receptor subunits, AMPA receptor subunits

Cross-Linking

EFNA2 interacts with multiple neurodegenerative disease pathways:

• [EPHA2 Receptor](/proteins/epha2-receptor)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Amyloid-Beta Metabolism](/mechanisms/amyloid-metabolism)
• [Microglia](/cell-types/microglia-neuroinflammation)
• [Dendritic Spines](/mechanisms/dendritic-spines)
• [Hippocampus](/brain-regions/hippocampus)
• [Cortex](/brain-regions/cortex)

Summary

EFNA2 (Ephrin A2) is a critical GPI-anchored ligand that mediates bidirectional signaling with EPHA receptors in the central nervous system. Through its roles in synaptic plasticity, dendritic spine dynamics, and neural circuit formation, EFNA2 plays essential functions in learning and memory. In Alzheimer's disease, EFNA2 dysfunction contributes to amyloid-beta accumulation, synaptic loss, and cognitive decline. The EFNA2-EPHA2 signaling axis represents a promising therapeutic target for neurodegenerative disease intervention.

References

External Links

• [NCBI Gene: EFNA2](https://www.ncbi.nlm.nih.gov/gene/1943)
• [Ensembl: ENSG00000146700](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000146700)
• [UniProt: O43923](https://www.uniprot.org/uniprotkb/O43923)
• [GeneCards: EFNA2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFNA2)